AVAILABILITY OF ANTI-NEOPLASTIC MEDICINES ACROSS EUROPE: FIRST RESULTS OF THE ESMO-LED EUROPEAN CONS...

Implications of the ESMO study findings on oncology pharmacy

M. Saar

Please set the zoomlevel of your browser to 100%.